These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37337881)
1. Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment. Eichenauer DA; Hartmann S Expert Rev Hematol; 2023; 16(8):607-615. PubMed ID: 37337881 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go? Eichenauer DA; Fuchs M Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444420 [TBL] [Abstract][Full Text] [Related]
3. How I treat nodular lymphocyte-predominant Hodgkin lymphoma. Eichenauer DA; Engert A Blood; 2020 Dec; 136(26):2987-2993. PubMed ID: 32877522 [TBL] [Abstract][Full Text] [Related]
4. Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management. Eichenauer DA; Engert A Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):324-328. PubMed ID: 29222274 [TBL] [Abstract][Full Text] [Related]
5. Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma. Eichenauer DA; Engert A Curr Opin Oncol; 2021 Sep; 33(5):395-399. PubMed ID: 34224482 [TBL] [Abstract][Full Text] [Related]
6. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677 [TBL] [Abstract][Full Text] [Related]
7. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma. Nogová L; Rudiger T; Engert A Hematology Am Soc Hematol Educ Program; 2006; ():266-72. PubMed ID: 17124071 [TBL] [Abstract][Full Text] [Related]
8. Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma. Spinner MA; Varma G; Advani RH Br J Haematol; 2019 Jan; 184(1):17-29. PubMed ID: 30485408 [TBL] [Abstract][Full Text] [Related]
9. SOHO State of the Art Updates and Next Questions |Treatment Approaches for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Binkley MS; Advani RH Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):471-476. PubMed ID: 37076366 [TBL] [Abstract][Full Text] [Related]
10. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion. Sidda A; Naleid NK; Manu G; Graffeo V; Jamil MO J Investig Med High Impact Case Rep; 2022; 10():23247096221111767. PubMed ID: 35861500 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment? Fanale M Hematology Am Soc Hematol Educ Program; 2013; 2013():406-13. PubMed ID: 24319212 [TBL] [Abstract][Full Text] [Related]
13. Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Eichenauer DA; Plütschow A; Schröder L; Fuchs M; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A Blood; 2018 Oct; 132(14):1519-1525. PubMed ID: 30064977 [TBL] [Abstract][Full Text] [Related]
15. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres. Illés A; Simon Z; Tóth E; Rosta A; Miltényi Z; Molnár Z Pathol Oncol Res; 2008 Dec; 14(4):411-21. PubMed ID: 18431694 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003 [TBL] [Abstract][Full Text] [Related]
17. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma. Maeda LS; Advani RH Curr Opin Oncol; 2009 Sep; 21(5):397-400. PubMed ID: 19606035 [TBL] [Abstract][Full Text] [Related]